High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab.
Oncol Lett
; 15(3): 3061-3067, 2018 Mar.
Article
in En
| MEDLINE
| ID: mdl-29435038
Full text:
1
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Year:
2018
Type:
Article